In a pilot study underway in the Pittsburgh area and several other cities, including Toronto, some paramedics will be administering a hyper concentrated saline solution containing Dextran. The hyper concentrated solution with Dextran is expected to provide better control of brain swelling and other decimating effects of brain trauma leading to increased survivability potential.
Studies like this in trauma medicine are leading to increased survivability from injuries which previously ended in death. But there are questions. As more individuals survive severe brain injury, will rehabilitation services be available? Will there be financial resources to pay for the extended care needed by these new survivors?